Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Rectal Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Endometrial Neoplasms 2Urinary Bladder Neoplasms 1Sarcoma, Ewing 1Recurrence 1Rectal Diseases 1Pancreatic Neoplasms 1Neoplasms by Site 1Nasopharyngeal Carcinoma 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Intestinal Neoplasms 1Intestinal Diseases 1Graft vs Host Disease 1Glioblastoma 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Gastric Cancer With Liver Metastases 1Esophageal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1

Interventions

Magnetic Resonance Spectroscopy 4Cyclophosphamide 4Specimen Handling 3Biopsy 3sodium-iodide symporter 2fludarabine 2cemiplimab 2X-Rays 2Whole-Body Irradiation 2Stem Cell Transplantation 2Photons 2Nivolumab 2Mycophenolic Acid 2Immunoglobulin G 2Disulfides 2Cyclosporine 2treosulfan 1ruxolitinib 1pembrolizumab 1fludarabine phosphate 1entrectinib 1duvelisib 1alectinib 1Vinblastine 1Tacrolimus 1Standard of Care 1Sirolimus 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Large-Cell, Anaplastic × Drug Therapy × 30 days × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡